C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2002
10/24/2002	US20020155441 Polypeptides for use in the, detection, prevention, treatment and diagnosis of malarial infection
10/24/2002	US20020155437 Detecting cancer cells in sample; obtain cells, detect preferential gene expression product, presence of expression product indicates cancer
10/24/2002	US20020155435 Detection of dengue virus
10/24/2002	US20020155434 Fusion protein for use in the treatment of viral diseases
10/24/2002	US20020155433 Polypeptide for use the prevention of infections associated with tissue grafting
10/24/2002	US20020155431 Screenining and detection of antiproliferative agentst; obtain tumor cells, incubate with antiproliferative agents, monitor reduction in tumor activity
10/24/2002	US20020155430 Lentiviral vector system for high quantity screening
10/24/2002	US20020155428 Retrovirus from the HIV group and its use
10/24/2002	US20020155421 Testing plasmid for endothelial cell mitogen protein; obtain cells, incubate in nutrient broths, monitor cell viability
10/24/2002	US20020155192 Yeast transport isoforms
10/24/2002	US20020155133 For use in anti-viral drug screening, and vaccine development
10/24/2002	US20020155132 Administering an effective amount of a lytic peptide for therapy of immunodeficiency virus infection in an infected animal
10/24/2002	US20020155131 Recombinant equine herpesvirus type 1 (EHV-1) comprising a dysfunctional gene 71 region and use thereof as a vaccine
10/24/2002	US20020155130 To immunity to mammals from infection and/or disease caused by a lentivirus, such as equine infectious anemia virus, human immunodeficiency virus (HIV), feline immunodeficiency virus, bovine immunodeficiency virus or simian immunodeficiency virus
10/24/2002	US20020155127 Genetic vaccine against human immunodeficiency virus
10/24/2002	US20020155125 Compositions and methods for therapy and diagnosis of breast cancer
10/24/2002	US20020155124 For enhancing the effect of vaccines in animals, such as domestic, sport, or pet species, and humans
10/24/2002	US20020155122 Immunologically significant herpes simplex virus antigens and methods for identifying and using same
10/24/2002	US20020155121 Virus coat protein/receptor chimeras and methods of use
10/24/2002	US20020155119 Isolation and use of fetal urogenital sinus expressed sequences
10/24/2002	US20020155117 Method for detecting organ allograft rejection and uses thereof
10/24/2002	US20020155115 Cancer therapy
10/24/2002	US20020155112 Administering recombinant polypeptide having ability to bind to Tumour necrosis factor (TNF- alpha ) for ameliorating the harmful effects of TNF in an animal
10/24/2002	US20020155111 For the vaccination of patients having malignant B cell diseases
10/24/2002	US20020155110 Soluble mast cell function associated antigen (MAFA) pharmaceutical compositions and methods of making and using them
10/24/2002	US20020155105 Administering to therapeutic formulation comprising peptides having sequence identity with ribosomal protein S1 which are immunoreactive with anti-dsDNA and anti-idiotypic antibody or antibody fragments immunoreactive with anti-dsDNA antibodies
10/24/2002	US20020155104 Altering T cell mediated immunity comprising altering local extracellular concentrations of tryptophan and tryptophan metabolites
10/24/2002	US20020155093 Administering immunologically-effective amount of therapeutic differentiation antigen of same type as target differentiation antigen, wherein therapeutic differentiation antigen is produced by expression in cells of second species
10/24/2002	EP1242157A4 Methods for preparing blood or plasma component solutions with improved concentrations
10/24/2002	DE10119905A1 Enriching intermediates in the mevalonate-independent pathway of isoprenoid synthesis, useful for therapeutic activation of T cells, comprises altering enzymatic activity in the pathway
10/24/2002	DE10119804A1 New peptides produced in primates during inflammation and sepsis, useful for diagnosis and treatment of these diseases, and their related antibodies
10/24/2002	DE10119294A1 New tumor-associated antigen B345, useful for diagnosis and immunotherapy of tumors, also related nucleic acid and antibodies
10/24/2002	DE10117858A1 New major histocompatibility complex tetramer, useful for studying the antigen-specific immune response, includes DsRed fluorescent protein as tetramerizing agent
10/24/2002	DE10113604A1 Verfahren zur Spaltung des humanen Wachstumshormons GH A process for cleavage of human growth hormone GH
10/24/2002	CA2447212A1 Secretory molecules
10/24/2002	CA2445990A1 Full-length human cdnas encoding potentially secreted proteins
10/24/2002	CA2444632A1 Vascular endothelial growth factor 2
10/24/2002	CA2444624A1 Vascular endothelial growth factor 2
10/24/2002	CA2444610A1 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
10/24/2002	CA2444530A1 Polypeptides, derivatives and uses thereof
10/24/2002	CA2444482A1 The use of genes encoding abc transporters to stimulate the production of secondary metabolites in biological cells
10/24/2002	CA2444470A1 Method and composition for prophylaxis of diabetes
10/24/2002	CA2444451A1 Transgenic non-human animals for pharmacological and toxicological studies
10/24/2002	CA2444298A1 Method for enhancing the translation and expression of recombinant proteins
10/24/2002	CA2444133A1 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
10/24/2002	CA2444087A1 Plant growth regulating genes, proteins and uses thereof
10/24/2002	CA2444048A1 Novel immunogenic compositions comprising modified and unmodified antigens
10/24/2002	CA2444047A1 Methods to inhibit viral replication
10/24/2002	CA2444001A1 Method and system for optimizing multi-epitope nucleic acid constructs and peptides encoded thereby
10/24/2002	CA2443995A1 Endothelial cell expression patterns
10/24/2002	CA2443968A1 Diagnosis and treatment of cancer: i
10/24/2002	CA2443909A1 Polynucleotides encoding two novel human g-protein coupled receptors, hgprbmy28 and hgprbmy29, and splice variants thereof
10/24/2002	CA2443897A1 Transporters and ion channels
10/24/2002	CA2443886A1 Methods and means for use of hla-dq restricted t-cell receptors and hla-dq-binding prolamine-derived peptides
10/24/2002	CA2443493A1 Surface proteins of streptococcus pyogenes
10/24/2002	CA2443147A1 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer
10/24/2002	CA2443141A1 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer
10/24/2002	CA2443123A1 Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
10/24/2002	CA2443088A1 Nucleic acid and corresponding protein entitled 121p2a3 useful in treatment and detection of cancer
10/24/2002	CA2442819A1 Elimination of endogenous porcine retrovirus
10/24/2002	CA2442729A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/24/2002	CA2442670A1 Method of treating or retarding the development of blindness
10/24/2002	CA2441876A1 Production of apomictic seed
10/24/2002	CA2441699A1 Methods and compositions for stable transgenic plant pharmaceuticals and their use as contraceptives
10/24/2002	CA2440846A1 Protein cluster v
10/24/2002	CA2439401A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/24/2002	CA2438107A1 G-protein coupled receptor molecules and uses thereof
10/24/2002	CA2437280A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/23/2002	EP1251178A1 Novel polypeptide-human shc protein 43 and polynucleotide encoding it
10/23/2002	EP1251177A2 Cytokine-, stress-, and oncoprotein-activited human protein kinase kinases
10/23/2002	EP1251176A2 Expression systems utilizing autolyzing fusion proteins and a reducing polypeptide
10/23/2002	EP1251173A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2002	EP1251172A1 Wt1-interacting protein wtip
10/23/2002	EP1251171A1 Novel endoplasmic reticulum-localized protein, remedies containing the same for diseases associated with glycoprotein abnormality, dna encoding this protein and gene remedies containing the same for treating diseases associated with glycoprotein abnormality
10/23/2002	EP1251170A2 Method and reagent for treatment of NF-kappaB dependent animal diseases
10/23/2002	EP1251139A2 Human mindin-like protein and nucleic acids encoding it
10/23/2002	EP1251138A1 Prion protein dimers useful for vaccination
10/23/2002	EP1251137A2 Use of insulin-like growth factor agonist peptides
10/23/2002	EP1250918A1 Cosmetic compositions containing archaebacteria extracts
10/23/2002	EP1250600A2 Diagnosis of tauopathies determining tau/phospho-tau ratio
10/23/2002	EP1250453A1 Use of multiple recombination sites with unique specificity in recombinational cloning
10/23/2002	EP1250450A2 Quorum sensing signaling in bacteria
10/23/2002	EP1250439A1 Expression and secretion vector for human interferon alpha and process for producing human interferon alpha by employing same
10/23/2002	EP1250438A2 Therapeutic polypeptides and methods for using same
10/23/2002	EP1250437A2 Membrane-bound proteins and nucleic acids encoding the same
10/23/2002	EP1250436A1 Toll-like receptor
10/23/2002	EP1250435A2 Human neurexin-like proteins and polynucleotides encoding the same
10/23/2002	EP1250434A2 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer
10/23/2002	EP1250433A1 Human membrane proteins and polynucleotides encoding the same
10/23/2002	EP1250432A2 Nuclear hormone receptors
10/23/2002	EP1250431A2 Modulation of gene expression in formation of fatty atherosclerotic lesions
10/23/2002	EP1250430A2 Regulatory sequence for the specific expression in dendritic cells and uses thereof
10/23/2002	EP1250428A1 32164 protein, a novel seven transmembrane protein
10/23/2002	EP1250427A2 Human membrane proteins and polynucleotides encodingthe same having homology to cd20 proteins and ige receptors
10/23/2002	EP1250426A2 Secreted and transmembrane polypeptides and nucleic acids encoding same
10/23/2002	EP1250425A2 Secreted human proteins, polynucleotides encoding them and methods of using the same
10/23/2002	EP1250424A1 Nucleic acid binding polypeptides characterized by flexible linkers connected nucleic acid binding modules
10/23/2002	EP1250419A2 Isolated polynucleotide encoding a novel phosphate transporter in plants and a method of modulating phosphate uptake in plants
10/23/2002	EP1250358A1 Therapeutic peptides
10/23/2002	EP1250357A1 Myostatin and mimetics thereof

1 ... 1734 1735 1736 1737 1738 1739 1740 1741 1742 1743 1744 1745 1746 1747 1748 1749 1750 1751 1752 1753 1754 ... 2916